ANGIODYNAMICS, INC.

Analyst Reco. AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Real-time Estimate Cboe BZX Other stock markets 08:36:19 29/04/2024 pm IST			5-day change	1st Jan Change
5.905 ^USD	+1.64%		-5.51%	-24.55%

08/04	North American Morning Briefing : Inflation Data, -2-	DJ
05/04	Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target	05/04	MT
Raymond James Adjusts Price Target on AngioDynamics to $10 From $12, Maintains Outperform Rating	09/01	MT
HC Wainwright Adjusts Price Target on AngioDynamics to $18 From $20, Keeps Buy Rating	08/01	MT
Raymond James Adjusts Price Target on AngioDynamics to $12 From $13, Keeps Outperform Rating	06/23/06	MT
HC Wainwright Adjusts AngioDynamics' Price Target to $20 From $19, Keeps Buy Rating	05/23/05	MT
HC Wainwright Starts AngioDynamics at Buy With $19 Price Target	25/23/25	MT
Canaccord Genuity Adjusts AngioDynamics Price Target to $20 From $18, Maintains Buy Rating	13/23/13	MT
Raymond James Downgrades AngioDynamics to Outperform From Strong Buy, Trims Price Target to $13 From $14	17/23/17	MT
Raymond James Adjusts Price Target on AngioDynamics to $14 From $22, Maintains Strong Buy Rating	03/23/03	MT
Raymond James Adjusts AngioDynamics' Price Target to $22 From $25, Keeps Strong Buy Rating	06/23/06	MT
Raymond James Adjusts AngioDynamics' Price Target to $25 from $27, Maintains Strong Buy Rating	07/22/07	MT
Raymond James Adjusts AngioDynamics' Price Target to $27 from $32, Keeps Strong Buy Rating	13/22/13	MT
ANGIODYNAMICS : Canaccord Genuity Upgrades AngioDynamics to Buy From Hold, Lifts Price Target to $37 From $28	15/21/15	MT
ANGIODYNAMICS : Oppenheimer Initiates Coverage on AngioDynamics With Perform Rating	20/21/20	MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $28 From $24, Maintains Hold Rating	14/21/14	MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $32 From $27, Keeps Strong Buy Rating	09/21/09	MT
ANGIODYNAMICS : Raymond James Adjusts AngioDynamics' Price Target to $27 from $24, Keeps Strong Buy Rating	31/21/31	MT
ANGIODYNAMICS : Canaccord Genuity Adjusts Price Target on AngioDynamics to $24 From $18, Maintains Hold Rating	31/21/31	MT
ANGIODYNAMICS : Raymond James Upgrades AngioDynamics to Strong Buy From Market Perform; Price Target is $18	25/20/25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer